DEC 03, 2015 9:59 AM PST

Inflammatory Molecules Linked to Rare Bone Growth Disease

WRITTEN BY: Kara Marker
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare genetic disease that causes bone to grow in abnormal areas like ligaments, tendons, and skeletal muscles. This atypical growth causes soft tissues to "undergo a metamorphosis" transforming normally flexible tissues into hard bone, "locking joints in place and making movement impossible" (National Organization for Rare Disorders).

In the past, treatment for this debilitating disorder included targeting the signaling pathway of bone morphogenetic proteins (BMPs), since the hyperactivity of these multi-functional growth factors is the root cause of FOP (NIH). However, in a new study published in PNASscientists from the Center for iPS Cell Research and Application (CiRA) at Kyoto University utilized the ability of induced pluripotent stem cells (iPSCs) to reprogram diseased cells in FOP patients. 
FOP in a mouse model: abnormal bone growth is circled

iPSCs are listed by the NIH as "adult cells that have been genetically reprogrammed to an embryonic stem cell–like state," meaning they are essentially identical donor cells that can be induced to differentiate differently, making them useful by scientists to repair diseased tissues. 

People with the genetic mutation for FOP develop symptoms of the disease after experiencing inflammation or trauma. The team from CiRA aimed to utilize the reprogrammable iPSCs in FOP mouse models to identify a certain inflammatory molecule triggering FOP development and potentially reverse its effect.

Studying alternative treatments to BMP signaling drug targets introduces an entirely new perspective on FOP treatment. CiRA scientists believed that the abnormality of BMP signaling causing FOP could be either unconditional BMP activation or atypically enhanced signaling strength when BMP is activated. Looking closer at the cause of FOP BMP signaling, they identified the role of Activin-A, a member of the transforming growth factor-beta superfamily, in the onset of FOP (NIH). 

“Using iPS cell technology, the scientists found that only cells harboring the FOP gene mutation would respond to Activin-A by significantly increasing their BMP signaling," a report from Kyoto University stated. 

Since immune actions in response to trauma trigger FOP, the treatment and study of FOP has historically been very complicated, seeing as surgical treatments to remove excessive bone only stimulate more irregular bone growth. The discovery of Activin-A's connection to BMP signaling offers a new method for repressing diseased bone growth in FOP patients and lends new information to the realm of drug discovery and bone growth in general. 

Watch the following video to learn more about the clinical application potential of iPSCs.


Source: Kyoto University 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 04, 2021
Genetics & Genomics
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
OCT 04, 2021
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
Since it's become quick and relatively inexpensive to sequence a human genome, researchers have gained unprecedented and ...
OCT 07, 2021
Neuroscience
Unclogged: Constipation Drug May Stimulate Memory and Cognition
OCT 07, 2021
Unclogged: Constipation Drug May Stimulate Memory and Cognition
A drug commonly prescribed for constipation shows promise for memory and cognition
OCT 08, 2021
Cannabis Sciences
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
OCT 08, 2021
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
As medical cannabis becomes legalized around the globe, patients need to explore which routes of cannabis delivery best ...
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
OCT 19, 2021
Health & Medicine
Acupuncture and Manual Therapy for Tension Headache: What's the Verdict?
OCT 19, 2021
Acupuncture and Manual Therapy for Tension Headache: What's the Verdict?
As if women didn't have enough to juggle with careers, motherhood, and monthly hormonal changes, cue the tension hea ...
OCT 25, 2021
Plants & Animals
Flaxseed Could Help Improve Inflammation And Oxidative Stress in Diabetes and CKD
OCT 25, 2021
Flaxseed Could Help Improve Inflammation And Oxidative Stress in Diabetes and CKD
Diabetes mellitus and chronic kidney disease (CKD) are common conditions that cause a range of morbidities, such as stro ...
Loading Comments...